JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$4.76B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.21B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$3.81B |
| 4 |
Apple
AAPL
|
+$3.39B |
| 5 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$3.1B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total International Bond ETF
BNDX
|
+$2.48B |
| 2 |
S&P Global
SPGI
|
+$2.45B |
| 3 |
Coca-Cola
KO
|
+$1.73B |
| 4 |
Adobe
ADBE
|
+$1.59B |
| 5 |
Schwab Short-Term US Treasury ETF
SCHO
|
+$1.3B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.97% |
| 2 | Technology | 21.69% |
| 3 | Healthcare | 9.58% |
| 4 | Consumer Discretionary | 9.07% |
| 5 | Financials | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2176
Caleres
CAL
$423M
| $13.4M | ﹤0.01% |
325,796
+87,471
| +37% | +$3.06M |
2013 Q2
43 quarters
|
|
2177
CALL
UnitedHealth
UNH
$340B
| $13.4M | ﹤0.01% |
27,000
-37,300
| -58% | -$19M |
2021 Q2
11 quarters
|
|
2178
CALL
Enphase Energy
ENPH
$4.42B
| $13.3M | ﹤0.01% |
110,300
+79,400
| +257% | +$9.26M |
2023 Q2
3 quarters
|
|
2179
CALL
Thermo Fisher Scientific
TMO
$250B
| $13.3M | ﹤0.01% |
22,900
-40,700
| -64% | -$22.8M |
2021 Q2
11 quarters
|
|
|
PINC
2180
DELISTED
Premier
PINC
| $13.3M | ﹤0.01% |
601,848
+131,658
| +28% | +$2.85M |
2013 Q4
41 quarters
|
|
|
2181
PUT
Coca-Cola
KO
$372B
| $13.3M | ﹤0.01% |
216,800
-16,000
| -7% | -$961K |
2014 Q2
39 quarters
|
|
2182
Graham Holdings Company
GHC
$4.89B
| $13.2M | ﹤0.01% |
17,242
+809
| +5% | +$579K |
2013 Q2
43 quarters
|
|
2183
TTM Technologies
TTMI
$14B
| $13.2M | ﹤0.01% |
844,606
+28,976
| +4% | +$430K |
2013 Q2
43 quarters
|
|
2184
Bio-Rad Laboratories Class A
BIO
$10.2B
| $13.2M | ﹤0.01% |
38,211
-8,153
| -18% | -$2.68M |
2013 Q2
43 quarters
|
|
|
CHCT
2185
Community Healthcare Trust
CHCT
$383M
| $13.2M | ﹤0.01% |
497,633
+137,890
| +38% | +$3.64M |
2016 Q1
32 quarters
|
|
2186
PUT
Universal Display
OLED
$3.67B
| $13.2M | ﹤0.01% |
78,300
-14,300
| -15% | -$2.49M |
2023 Q2
3 quarters
|
|
|
TCN
2187
DELISTED
Tricon Residential Inc.
TCN
| $13.2M | ﹤0.01% |
1,181,950
-399,883
| -25% | -$4.26M |
2021 Q4
9 quarters
|
|
2188
PUT
Elevance Health
ELV
$85.6B
| $13.2M | ﹤0.01% |
25,400
+10,400
| +69% | +$5.17M |
2022 Q2
7 quarters
|
|
2189
CALL
Lowe's Companies
LOW
$101B
| $13.1M | ﹤0.01% |
51,500
+24,200
| +89% | +$5.56M |
2016 Q4
29 quarters
|
|
2190
Vanguard Global ex-US Real Estate ETF
VNQI
$3.24B
| $13.1M | ﹤0.01% |
310,874
+8,715
| +3% | +$356K |
2018 Q2
23 quarters
|
|
|
EVRI
2191
DELISTED
Everi Holdings
EVRI
| $13.1M | ﹤0.01% |
1,301,926
+455,147
| +54% | +$4.71M |
2017 Q1
28 quarters
|
|
2192
PUT
Home Depot
HD
$281B
| $13M | ﹤0.01% |
34,000
-199,700
| -85% | -$73M |
2017 Q2
27 quarters
|
|
2193
CALL
Diamondback Energy
FANG
$51.5B
| $13M | ﹤0.01% |
65,800
-13,700
| -17% | -$2.33M |
2022 Q1
8 quarters
|
|
2194
iShares 10+ Year Investment Grade Corporate Bond ETF
IGLB
$2.52B
| $13M | ﹤0.01% |
252,940
-35,295
| -12% | -$1.81M |
2019 Q2
19 quarters
|
|
2195
CALL
Edwards Lifesciences
EW
$50.3B
| $13M | ﹤0.01% |
136,300
+9,500
| +7% | +$798K |
2023 Q3
2 quarters
|
|
2196
National Health Investors
NHI
$3.19B
| $13M | ﹤0.01% |
207,243
-4,070
| -2% | -$230K |
2014 Q4
37 quarters
|
|
2197
PUT
The Kraft Heinz Company
KHC
$25.9B
| $13M | ﹤0.01% |
352,200
-81,200
| -19% | -$2.95M |
2015 Q4
33 quarters
|
|
2198
BlueLinx
BXC
$586M
| $13M | ﹤0.01% |
99,682
-123
| -0.1% | -$14.5K |
2017 Q2
27 quarters
|
|
2199
Paymentus
PAY
$3.98B
| $13M | ﹤0.01% |
570,452
+1,381
| +0.2% | +$24.9K |
2021 Q2
11 quarters
|
|
2200
CALL
Johnson & Johnson
JNJ
$610B
| $13M | ﹤0.01% |
82,000
-268,800
| -77% | -$42.8M |
2014 Q3
38 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2024 Portfolio in Review
As of Q1 2024, JP Morgan Chase held 8,132 positions worth $1.18T, up 14% from $1.04T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
JP Morgan Chase deployed $48.7B of net new capital in Q1 2024, opening 625 new positions and adding to 3,255 existing holdings. Its largest new stake was Flutter Entertainment: 1,314,201 shares worth $260M.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, down from 26% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Vanguard Total International Bond ETF, an estimated $2.48B trimmed.
- JP Morgan Chase's largest Q1 2024 buy was Flutter Entertainment: 1,314,201 shares worth $260M.
- JP Morgan Chase added most to Vanguard S&P 500 ETF in Q1 2024, an estimated $4.76B increase.
- JP Morgan Chase's biggest Q1 2024 reduction was Vanguard Total International Bond ETF, cutting an estimated $2.48B.
- JP Morgan Chase fully exited BlackRock Flexible Income ETF in Q1 2024, selling an estimated $139M.
- JP Morgan Chase's ten largest holdings make up 21% of its $1.18T portfolio in Q1 2024.
- JP Morgan Chase opened 625 new positions and closed 764 in Q1 2024.
- JP Morgan Chase's portfolio value rose 14% quarter-over-quarter to $1.18T.
Based on JP Morgan Chase's 13F filing for Q1 2024, filed 10 May 2024.